Anath Shalev, MD
  • Director, UAB Comprehensive Diabetes Center
  • University of Alabama at Birmingham
  • Birmingham, AL USA


Dr. Anath Shalev received her Medical Degree and training at the University of Basel, Switzerland and took a Postgraduate Course in Experimental Biology and Medicine at the University of Zurich, Switzerland. She then came to the U.S. as a research fellow at Harvard Medical School, Boston, MA, and did her fellowship training in Endocrinology, Diabetes and Metabolism at the National Institutes of Health (NIH) in Bethesda, MD. In 2002, she became an Assistant Professor at the University of Wisconsin-Madison and was later promoted to Associate Professor and Director of Endocrinology, Diabetes and Metabolism Research there. Dr. Shalev moved to the University of Alabama at Birmingham (UAB) as a Professor of Medicine in 2010 to become the Director of the UAB Comprehensive Diabetes Center and the Nancy R. and Eugene C. Gwaltney Family Endowed Chair in Juvenile Diabetes Research.
Dr. Shalev’s laboratory has pioneered the role of thioredoxin-interacting protein (TXNIP) in pancreatic beta cell biology, diabetic complications and as a novel therapeutic target for diabetes and continues to work on the molecular biology of TXNIP signaling and the translation of the findings into clinical practice.